Standard Biotools (LAB) Free Cash Flow (2010 - 2026)
Standard Biotools (LAB) posted quarterly Free Cash Flow of -$46.9 million for Q1 2026, down 32.77% year-over-year from -$69.8 million in Q1 2025, and down 2361.49% quarter-over-quarter from -$1.9 million in Q4 2025.
Standard Biotools (LAB) Free Cash Flow (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Free Cash Flow for 17 consecutive years, with -$46.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 32.77% year-over-year to -$46.9 million; the TTM figure through Mar 2026 stood at -$86.8 million (up 26.05% YoY), while the FY2025 annual figure was -$75.2 million, up 48.24% from the prior year.
- Free Cash Flow slipped to -$46.9 million in Q1 2026 per LAB's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$1.9 million in Q4 2025 and bottomed at -$63.3 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$23.8 million across 5 years, with a median of -$19.9 million in 2022.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 3887.2% — and 2025, when it surged 82.51%.
- Standard Biotools' Free Cash Flow stood at -$19.9 million in 2022, then jumped by 43.28% to -$11.3 million in 2023, then grew by 3.61% to -$10.9 million in 2024, then soared by 82.51% to -$1.9 million in 2025, then slumped by 2361.49% to -$46.9 million in 2026.
- Business Quant data shows LAB's Free Cash Flow at -$46.9 million in Q1 2026, -$1.9 million in Q4 2025, and -$22.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -10.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.66 Mn |
| Jun 30, 2026 | -10.66 Mn |
| Mar 31, 2026 | -46.92 Mn |
| Mar 31, 2026 | -46.92 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -22.15 Mn |
| Sep 30, 2025 | -22.15 Mn |
| Jun 30, 2025 | -15.80 Mn |
| Jun 30, 2025 | -15.80 Mn |
| Mar 31, 2025 | -35.34 Mn |
| Mar 31, 2025 | -35.34 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Sep 30, 2024 | -32.84 Mn |
| Sep 30, 2024 | -32.84 Mn |
| Jun 30, 2024 | -38.27 Mn |
| Jun 30, 2024 | -38.27 Mn |
| Mar 31, 2024 | -63.26 Mn |
| Mar 31, 2024 | -63.26 Mn |